ICRA Nepal Reaffirms BBB- Issuer Rating of Time Pharmaceuticals
Fri, Mar 13, 2026 10:30 AM on Latest, Corporate, Credit Rating,
ICRA Nepal Limited has reaffirmed the issuer rating of [ICRANP-IR] BBB- for Time Pharmaceuticals Limited and removed it from the ‘Watch with Negative Implications’ category.
This rating indicates a moderate level of safety in meeting financial obligations. The rating reflects the company’s overall creditworthiness rather than any specific debt instrument.
In the rating scale from AA to C, plus (+) or minus (–) signs indicate the entity’s relative position within the category, with BBB+ ranking above BBB and BBB- slightly below BBB.
